Geron
GERN
#6280
Rank
$0.83 B
Marketcap
$1.31
Share price
3.15%
Change (1 day)
-67.09%
Change (1 year)

Earnings for Geron (GERN)

Earnings in 2025 (TTM): -$45.93 Million USD

According to Geron's latest financial reports the company's current earnings are $0.18 Billion USD. In 2024 the company made an earning of -$0.16 Billion USD, an increase over its 2023 earnings that were of -$0.18 Billion USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Geron from 1996 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -$45.93 Million-70.57%
2024 -$0.16 Billion-11.23%
2023 -$0.18 Billion30.22%
2022 -$0.14 Billion20.15%
2021 -$0.12 Billion50.08%
2020 -$74.88 Million4.46%
2019 -$71.68 Million130.68%
2018 -$31.08 Million8.84%
2017 -$28.55 Million-3.08%
2016 -$29.46 Million-22080.6%
2015 $0.13 M-100.38%
2014 -$35.59 Million-7.14%
2013 -$38.33 Million
2011 -$90.67 Million19.04%
2010 -$76.17 Million8.45%
2009 -$70.24 Million-2.51%
2008 -$72.05 Million14.65%
2007 -$62.84 Million32.68%
2006 -$47.36 Million25.59%
2005 -$37.71 Million4.36%
2004 -$36.14 Million19.73%
2003 -$30.18 Million-15.46%
2002 -$35.7 Million1.94%
2001 -$35.02 Million33.59%
2000 -$26.22 Million27.53%
1999 -$20.56 Million63.13%
1998 -$12.6 Million15.6%
1997 -$10.9 Million-10.66%
1996 -$12.2 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Eterna Therapeutics
ERNA
-$9.49 Million-79.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
$9.88 B-21,626.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
$0.11 B-351.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Incyte
INCY
$1.58 B-3,558.39%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
-$69.24 Million 50.77%๐Ÿ‡บ๐Ÿ‡ธ USA